A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis
About this item
Full title
Author / Creator
Nyang’wa, Bern-Thomas , Berry, Catherine , Kazounis, Emil , Motta, Ilaria , Parpieva, Nargiza , Tigay, Zinaida , Solodovnikova, Varvara , Liverko, Irina , Moodliar, Ronelle , Dodd, Matthew , Ngubane, Nosipho , Rassool, Mohammed , McHugh, Timothy D. , Spigelman, Melvin , Moore, David A.J. , Ritmeijer, Koert , du Cros, Philipp , Fielding, Katherine and TB-PRACTECAL Study Collaborators
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In patients with rifampin-resistant tuberculosis, all-oral treatment regimens that are more effective, shorter, and have a more acceptable side-effect profile than current regimens are needed.
We conducted an open-label, phase 2-3, multicenter, randomized, controlled, noninferiority trial to evaluate the efficacy and safety of three 24-week, all...
Alternative Titles
Full title
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis
Authors, Artists and Contributors
Author / Creator
Berry, Catherine
Kazounis, Emil
Motta, Ilaria
Parpieva, Nargiza
Tigay, Zinaida
Solodovnikova, Varvara
Liverko, Irina
Moodliar, Ronelle
Dodd, Matthew
Ngubane, Nosipho
Rassool, Mohammed
McHugh, Timothy D.
Spigelman, Melvin
Moore, David A.J.
Ritmeijer, Koert
du Cros, Philipp
Fielding, Katherine
TB-PRACTECAL Study Collaborators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2756703159
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2756703159
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2117166
